Moderna also hopes that combining the shots will help improve vaccine rates. Poland, however, is not sure people will like ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...

Momentum is building to scale back the current recommendation that all children over 6 months old get immunized against the ...

In a study published in the Journal of the American Medical Association, researchers from Moderna reported that the new combo ...

Moderna on Thursday reported first-quarter profit and sales that beat Wall Street estimates, helped by the company's ...

MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...

Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its ...

Moderna could face suspension from Britain’s pharmaceutical trade body following a string of breaches of the regulatory code.

Moderna reiterated its full-year 2025 product sales forecast of $1.5 billion to $2.5 billion, with most expected in the ...

Moderna, known for its COVID-19 vaccines, has been found guilty of 10 breaches of regulatory code after it marketed its ...

Biotechnology company Moderna (NASDAQ:MRNA) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 35.3% ...